NIH-Funded Scientists Uncover Clues To Precancer And Tumor Biology

(MENAFN- PR Newswire)

A collection of new papers highlight discoveries from the Human Tumor Atlas Network, a Cancer MoonshotSM initiative

BETHESDA, Md., Oct. 30, 2024 /PRNewswire/ --

What:
New insights from multiple studies provide critical information on how cancer tumors develop, spread, and respond to treatments. The 10 studies from the Human Tumor Atlas Network (HTAN), a National Institutes of health (NIH)-funded Cancer MoonshotSM
initiative to construct three-dimensional maps of human tumors, will be published Oct. 31, 2024, across several Nature journals.

Several studies explore the role of the tumor microenvironment and the immune system in promoting the spread of cancer and its resistance to treatment. Three studies map the trajectory of precancerous colorectal tissues toward cancer by measuring the contributions of multiple molecular and cellular events. Multiple new HTAN papers describe the development of innovative single-cell technology and analysis platforms. An accompanying research briefing by W. Kimryn Rathmell, M.D., Ph.D., director of NIH's National Cancer Institute (NCI), and Dinah Singer, Ph.D., NCI deputy director for scientific strategy and development, discusses the history, progress, and future of HTAN.

Launched in 2018, HTAN constructs three-dimensional maps of human tumors that capture their molecular features and surrounding microenvironments over time.
The work is being done by teams of investigators from research institutions across the country using a variety of technologies and computational approaches to study tumors at the single-cell level. This comprehensive, publicly available resource aims to help researchers better understand the development and progression of cancer to inform its prevention and treatment. The first tumor atlas studies from this initiative were published in 2020 and 2021.

Who: Shannon Hughes, Ph.D., Division of Cancer Biology, NCI; Sean Hanlon, Ph.D., Center for Strategic Scientific Initiatives, NCI; Sudhir Srivastava, Ph.D., M.P.H., Division of Cancer Prevention, NCI

The studies: The collection page is available at .

About the National Cancer Institute (NCI):
NCI
leads the National Cancer Program and NIH's efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI website at
cancer
or call NCI's contact center, the Cancer Information Service, at 1-800-4-CANCER (1-800-422-6237).

About the National Institutes of Health (NIH):
NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit
nih .

SOURCE NATIONAL CANCER INSTITUTE

MENAFN30102024003732001241ID1108834822